DL-Thyroxine is a halogenated, iodinated amino acid derivative related to the thyroid hormone scaffold, featuring a diphenyl ether core with two iodine substituents and a phenolic hydroxyl group, and bearing an amino acid-like side chain that contains an amino functionality. The molecule presents multiple aromatic rings and strongly electron-withdrawing iodine substituents, with the amino and carboxyl-related functionality arranged as a derivative consistent with an amino acid class rather than a free proteinogenic amino acid, and the "DL" designation indicates a racemic mixture of stereoisomers at the chiral center(s) present in the structure. It is employed in chemical biology and analytical chemistry contexts such as molecular labeling, binding or transport studies using defined hormone-like structures, and as a reference material for method development involving iodinated aromatic amino acid derivatives.
CAT No: CP19303
DL-Thyroxine is a racemic thyroid hormone analog featuring a diphenyl ether core with two iodine substituents on the outer aromatic rings and a side-chain containing a terminal carboxylic acid. The molecule bears a chiral center at the alanine-like side chain (DL configuration), enabling stereochemically defined interactions when resolved or incorporated into chiral derivatization workflows. Thyroxine's phenolic hydroxyl groups and carboxylic acid provide distinct handle points for esterification, ether formation, and amide coupling, while the iodine pattern supports electrophilic aromatic substitution chemistry and radiolabel-compatible routes. As an amino acid-derived hormone scaffold, DL-Thyroxine functions as a chemically stable, halogenated intermediate for downstream synthesis, analytical standards, and structure-controlled biochemical reagent preparation.
1. Analytical Reference Standards
DL-Thyroxine is used in analytical research workflows where thyroid hormone identity, iodination pattern, and stereochemical composition must be tracked across method development and validation. The diphenyl ether framework with phenolic hydroxyl groups and the carboxylic acid enables robust derivatization strategies for chromatographic behavior tuning, including ester or amide formation to improve extraction and ionization characteristics. The racemic DL stereochemistry supports calibration and specificity testing for chiral separation methods, while the iodine atoms provide strong mass spectrometric signatures for sensitive detection. Downstream use includes preparation of reference mixtures, internal standards, and impurity mapping materials for thyroid hormone profiling in complex matrices.
2. Peptide Conjugation Chemistry
DL-Thyroxine can be applied in chemical biology and biomolecule labeling contexts where thyroid hormone motifs are conjugated to proteins, peptides, or polymers for receptor-binding studies. The carboxylic acid and phenolic hydroxyl groups support selective functional group conversion into activated esters or amide-forming intermediates, enabling controlled attachment to amine-bearing biomolecules. The halogenated aromatic core can be retained during coupling to preserve the recognition-relevant iodine substitution pattern, while stereochemical mixtures can be used to probe stereodependence when paired with chiral controls. Resulting conjugates serve as tools for studying hormone transport, binding kinetics, and molecular recognition, and they can be further processed into labeled probes for downstream assay development.
3. Chiral Resolution Intermediates
DL-Thyroxine is suitable for stereochemical research and chiral synthesis planning because the compound contains a stereogenic center at the side chain that can be resolved or transformed into stereodefined derivatives. The presence of phenolic hydroxyl groups and the carboxylic acid supports formation of diastereomeric salts, ester derivatives, or protected intermediates that can be separated to obtain single-enantiomer material. The iodine-substituted aromatic system remains chemically informative during resolution, allowing monitoring by mass spectrometry and iodine-specific detection approaches. Downstream utility includes generating enantiopure thyroxine analogs for stereoselective receptor studies, chiral method benchmarking, and synthesis of defined hormone-based standards.
4. Synthetic Organic Intermediate
DL-Thyroxine functions as an amino acid-derived, halogenated aromatic intermediate for fine chemical synthesis where controlled functional group interconversion is required. The carboxylic acid and phenolic hydroxyl groups can be converted into protected or activated derivatives that participate in coupling chemistry, while the diphenyl ether scaffold tolerates electrophilic aromatic substitution and selective functionalization strategies under appropriate conditions. The iodine pattern enables downstream derivatization routes that preserve the halogenated motif for structure-controlled analog libraries. Resulting products can feed into peptidomimetic or hormone-mimicking scaffold construction, as well as into process chemistry intermediate preparation for specialized reagents used in analytical and biochemical research.
5. Pharmaceutical Manufacturing Inputs
DL-Thyroxine can be employed in pharmaceutical manufacturing-adjacent workflows focused on reference material preparation, impurity standards, and intermediate handling for hormone-related synthetic campaigns. The stable iodinated aromatic structure and the functional acid and phenol functionalities allow conversion into standardized forms for process analytics, including derivatized forms used to monitor identity and residual starting material. Racemic composition can be used as a defined input for process development experiments where stereochemical separation steps are evaluated downstream. Broader industrial relevance includes supporting quality-by-design studies for thyroid hormone analog synthesis, where consistent structural features and measurable spectrometric signatures are required for robust manufacturing control.
1. Cationic cell-penetrating peptides are potent furin inhibitors
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More